162 related articles for article (PubMed ID: 10429624)
1. Surgical procedure and local recurrence in 223 patients treated 1982-1997 according to two osteosarcoma chemotherapy protocols. The Scandinavian Sarcoma Group experience.
Brosjö O
Acta Orthop Scand Suppl; 1999 Jun; 285():58-61. PubMed ID: 10429624
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and tumor response in osteosarcoma and Ewing's sarcoma, according to treatment protocols SSG II, SSG VIII, ISG/SSG I, SSG IV and SSG IX.
Holmström T; Böhling T; Akerman M; Willén H; Stenwig E; Bertoni F
Acta Orthop Scand Suppl; 1999 Jun; 285():27-9. PubMed ID: 10429618
[TBL] [Abstract][Full Text] [Related]
3. Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years.
Smeland S; Bruland OS; Hjorth L; Brosjö O; Bjerkehagen B; Osterlundh G; Jakobson A; Hall KS; Monge OR; Björk O; Alvegaard TA
Acta Orthop; 2011 Apr; 82(2):211-6. PubMed ID: 21434784
[TBL] [Abstract][Full Text] [Related]
4. Limb-sparing in patients with non-metastatic high-grade osteosarcoma.
Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
J BUON; 2009; 14(1):63-9. PubMed ID: 19373949
[TBL] [Abstract][Full Text] [Related]
5. Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders.
Smeland S; Müller C; Alvegard TA; Wiklund T; Wiebe T; Björk O; Stenwig AE; Willén H; Holmström T; Follerås G; Brosjö O; Kivioja A; Jonsson K; Monge O; Saeter G
Eur J Cancer; 2003 Mar; 39(4):488-94. PubMed ID: 12751380
[TBL] [Abstract][Full Text] [Related]
6. Treatment of non-metastatic high-grade osteosarcoma (study of 30 cases treated with Scandinavian osteosarcoma protocol XIV and surgery).
Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
Prilozi; 2008 Dec; 29(2):309-23. PubMed ID: 19259055
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis comparing efficiency of limb-salvage surgery vs amputation on patients with osteosarcoma treated with neoadjuvant chemotherapy.
Abdelgawad MA; Parambi DGT; Ghoneim MM; Alotaibi NH; Alzarea AI; Hassan AH; Abdelrahim MEA
Int Wound J; 2022 Nov; 19(7):1616-1624. PubMed ID: 35122396
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy in Ewing's sarcoma. The Scandinavian Sarcoma Group experience.
Elomaa I; Blomqvist C; Saeter G; Nilbert M; Monge OR; Wiebe T; Alvegård TA
Acta Orthop Scand Suppl; 1999 Jun; 285():69-73. PubMed ID: 10429626
[TBL] [Abstract][Full Text] [Related]
9. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
[TBL] [Abstract][Full Text] [Related]
10. Local and systemic control for osteosarcoma of the extremity treated with neoadjuvant chemotherapy and limb salvage surgery: the Rizzoli experience.
Bacci G; Ruggieri P; Bertoni F; Ferrari S; Longhi A; Biagini R; Zavatta M; Versari M; Forni C
Oncol Rep; 2000; 7(5):1129-33. PubMed ID: 10948351
[TBL] [Abstract][Full Text] [Related]
11. Does amputation offer any survival benefit over limb salvage in osteosarcoma patients with poor chemonecrosis and close margins?
Reddy KI; Wafa H; Gaston CL; Grimer RJ; Abudu AT; Jeys LM; Carter SR; Tillman RM
Bone Joint J; 2015 Jan; 97-B(1):115-20. PubMed ID: 25568424
[TBL] [Abstract][Full Text] [Related]
12. Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution.
Bacci G; Forni C; Longhi A; Ferrari S; Mercuri M; Bertoni F; Serra M; Briccoli A; Balladelli A; Picci P
J Surg Oncol; 2007 Aug; 96(2):118-23. PubMed ID: 17577221
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of randomized control trials of surgical methods with osteosarcoma outcomes.
He X; Gao Z; Xu H; Zhang Z; Fu P
J Orthop Surg Res; 2017 Jan; 12(1):5. PubMed ID: 28086937
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy.
Bacci G; Ferrari S; Mercuri M; Bertoni F; Picci P; Manfrini M; Gasbarrini A; Forni C; Cesari M; Campanacci M
Acta Orthop Scand; 1998 Jun; 69(3):230-6. PubMed ID: 9703394
[TBL] [Abstract][Full Text] [Related]
15. The treatment of osteosarcoma: present trends. The Scandinavian Sarcoma Group experience.
Solheim OP; Saeter G; Elomaa I; Alvegård TA
Ann Oncol; 1992 Apr; 3 Suppl 2():S7-11. PubMed ID: 1622872
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of osteosarcoma treated by limb-salvage surgery: the ten-year intergroup study in Japan.
Tsuchiya H; Tomita K
Jpn J Clin Oncol; 1992 Oct; 22(5):347-53. PubMed ID: 1469796
[TBL] [Abstract][Full Text] [Related]
17. Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation: local and systemic control by amputation or limb salvage after preoperative chemotherapy.
Bacci G; Ferrari S; Longhi A; Donati D; Manfrini M; Giacomini S; Briccoli A; Forni C; Galletti S
Acta Orthop Scand; 2003 Aug; 74(4):449-54. PubMed ID: 14521297
[TBL] [Abstract][Full Text] [Related]
18. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin.
Bacci G; Picci P; Ruggieri P; Mercuri M; Avella M; Capanna R; Brach Del Prever A; Mancini A; Gherlinzoni F; Padovani G
Cancer; 1990 Jun; 65(11):2539-53. PubMed ID: 2337871
[TBL] [Abstract][Full Text] [Related]
19. An update of Scandinavian studies of osteosarcoma.
Elomaa I
Cancer Treat Res; 1993; 62():293-8. PubMed ID: 8096745
[No Abstract] [Full Text] [Related]
20. Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen.
Bacci G; Ferrari S; Bertoni F; Mercuri M; Forni C; Sottili S; Gasbarrini A; Tienghi A; Cesari M; Campanacci M
J Chemother; 1997 Aug; 9(4):293-9. PubMed ID: 9269611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
